MAIA Biotechnology (MAIA) announced updated data from its THIO-101 pivotal Phase 2 clinical trial evaluating its lead clinical candidate, THIO, ...
CHICAGO - MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company with a market capitalization of $49.4 million, has announced updated data from its Phase 2 clinical ...
The research got the thrust after the Department of Biotechnology (DBT), Ministry of Science and Technology and Indian Space ...
The life sciences industry has a significant impact on the North Carolina economy. Using data from NCBiotech’s life sciences ...
Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Biotechnology industry for Monday, February 03, 2025. Let’s ...
In this opinion piece, Sylvia Wulf, the Biotechnology Innovation Organization’s interim head of agriculture and environment, ...
China Universal Asset Management Co. Ltd. boosted its holdings in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Free ...
11h
China Universal Asset Management Co. Ltd. boosted its holdings in shares of Prothena Co. plc (NASDAQ:PRTA – Free Report) by ...
Scientists have completed construction of the final chromosome in the worlds' first synthetic yeast genome following more than a decade of work, opening new possibilities for creating resilient, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback